Potential underlying mechanisms of ethambutol induced optic neuropathy: Evidence from in vitro to clinical studies
Food and Chemical Toxicology · 2023-12 · 182 · 114176
DOI: 10.1016/j.fct.2023.114176 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2023-12. Verfasst von Pichaya Kulniwatcharoen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Depar…. Hauptthemen laut MEDLINE: Ethambutol, Optic Nerve Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Science and Technology Development Agency, National Research Council of Thailand, Chiang Mai University.
Abstract (Originalsprache)
Ethambutol is an antibiotic widely used for treatment of Mycobacterium species. Although it is safe to use in patients, the ocular toxic impact, including optic neuropathy and retinopathy, can be observed in patients using ethambutol. After discontinuation of the drug, the ocular toxic effects can be reversible in some patients, but some are not. Ethambutol-induced optic neuropathy has been recognized for more than six decades and the prevalence of optic neuropathy from a standard dose of ethambutol has been reported as 0.7-1.29%. Several factors associated with ethambutol-induced optic neuropathy include dosage/duration of drug, the medical conditions of patients such as renal and hepatic dysfunction and preexisting mitochondrial mutations. Currently, there is no specific treatment and prevention of ethambutol-induced optic neuropathy. In addition, the potential underlying mechanisms of ethambutol-induced optic neuropathy is still unclear. Therefore, this review aimed to summarize and discuss evidence from clinical, in vitro, and in vivo studies in order to explore the potential pathophysiology of ethambutol-induced optic neuropathy. Any contradictory findings are also included and discussed. The insights gained from the review will facilitate the discovery of novel approaches for prevention and treatment of optic neuropathy-induced by ethambutol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Ch…
- Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai Univ…
Förderung
- National Science and Technology Development Agency
- National Research Council of Thailand
- Chiang Mai University
Zitieren
APA
Kulniwatcharoen, P., Hansapinyo, L., Chattipakorn, N., & Chattipakorn, S. C. (2023). Potential underlying mechanisms of ethambutol induced optic neuropathy: Evidence from in vitro to clinical studies. Food and Chemical Toxicology, 182, 114176. https://doi.org/10.1016/j.fct.2023.114176
Vancouver
Kulniwatcharoen P, Hansapinyo L, Chattipakorn N, Chattipakorn SC. Potential underlying mechanisms of ethambutol induced optic neuropathy: Evidence from in vitro to clinical studies. Food and Chemical Toxicology. 2023;182:114176. doi:10.1016/j.fct.2023.114176
BibTeX
@article{Kulniwatcharoen2023,
author = {Kulniwatcharoen, Pichaya and Hansapinyo, Linda and Chattipakorn, Nipon and Chattipakorn, Siriporn C},
title = {Potential underlying mechanisms of ethambutol induced optic neuropathy: Evidence from in vitro to clinical studies},
journal = {Food and Chemical Toxicology},
year = {2023},
volume = {182},
pages = {114176},
doi = {10.1016/j.fct.2023.114176}
}
EUVIMED